Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Gonadotropins vs Ovarian Drilling in CC-Resistant PCOS
NCT06486870Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jan 2020
- Primary completion
- Jan 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of letrozole in polycystic ovary syndrome (PCOS), sponsored by Cairo University. Started Jan 2020; status: completed.
02
Drugs
letrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on NCT06486870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06486870.